Schedule 13G ownership disclosure

LA JOLLA PHARMACEUTICAL CO

Security class unavailable · CUSIP: 503459604

Event date: 2019-02-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,375,000
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-007109
Form type
SC 13G
Filer
LA JOLLA PHARMACEUTICAL CO
CIK
CIK 920465
Filed
Feb 11, 2019
Reporting period
Feb 01, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub